Search alternatives:
largest decrease » marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
largest decrease » marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
-
5401
Table_1_Successful treatment of refractory palmoplantar pustulosis by upadacitinib: report of 28 patients.DOC
Published 2024“…The mean age was (36.3 ± 10.5) years. After 12 weeks of treatment, PPPASI scores decreased from baseline (13.86 ± 2.76) to (5.56 ± 1.08), with a statistically significant difference (p < 0.05). …”
-
5402
Learning-related changes in assembly–reader relations.
Published 2025“…<p><b>(a)</b> Examples readers increasing (left) or decreasing (right) their responses (shaded area: mean ± s.e.m.) to assembly activations after fear conditioning (green) relative to before conditioning (light green). …”
-
5403
Summary of subgroup analysis results.
Published 2025“…Subgroup analysis showed that increased KIM-1 in urine or blood was strongly associated with ESRD, and decreased Fetuin-A levels in Asians had a significant association with the incidence of ESRD.…”
-
5404
PRISMA Flow Chart 2020.
Published 2025“…Subgroup analysis showed that increased KIM-1 in urine or blood was strongly associated with ESRD, and decreased Fetuin-A levels in Asians had a significant association with the incidence of ESRD.…”
-
5405
Included and excluded studies.
Published 2025“…Subgroup analysis showed that increased KIM-1 in urine or blood was strongly associated with ESRD, and decreased Fetuin-A levels in Asians had a significant association with the incidence of ESRD.…”
-
5406
Characteristics of included studies.
Published 2025“…Subgroup analysis showed that increased KIM-1 in urine or blood was strongly associated with ESRD, and decreased Fetuin-A levels in Asians had a significant association with the incidence of ESRD.…”
-
5407
Extraction data table.
Published 2025“…Subgroup analysis showed that increased KIM-1 in urine or blood was strongly associated with ESRD, and decreased Fetuin-A levels in Asians had a significant association with the incidence of ESRD.…”
-
5408
Table 1_Near-infrared prediction of total phosphorus in leaves content in korla fragrant pear with growth period specificity via spectral modeling.docx
Published 2025“…Compared with the general model, the Coefficient of determination (R<sup>2</sup>) increased by 0.05-0.16, and the root mean square error decreased by 0.0029-0.0079. This study successfully constructed a technical system of “Growth period-Preprocessing-Model”. …”
-
5409
Table 2_Changes in symptom pattern in Meniere's disease by duration: the need for comprehensive management.docx
Published 2024“…The study population comprised 79.5% females and 20.5% males, with a mean age of 63 years and an average disease duration of 15.2 years.…”
-
5410
Data Sheet 3_Changes in symptom pattern in Meniere's disease by duration: the need for comprehensive management.pdf
Published 2024“…The study population comprised 79.5% females and 20.5% males, with a mean age of 63 years and an average disease duration of 15.2 years.…”
-
5411
Table 1_Changes in symptom pattern in Meniere's disease by duration: the need for comprehensive management.docx
Published 2024“…The study population comprised 79.5% females and 20.5% males, with a mean age of 63 years and an average disease duration of 15.2 years.…”
-
5412
Data Sheet 2_Changes in symptom pattern in Meniere's disease by duration: the need for comprehensive management.pdf
Published 2024“…The study population comprised 79.5% females and 20.5% males, with a mean age of 63 years and an average disease duration of 15.2 years.…”
-
5413
Image 6_Changes in symptom pattern in Meniere's disease by duration: the need for comprehensive management.tif
Published 2024“…The study population comprised 79.5% females and 20.5% males, with a mean age of 63 years and an average disease duration of 15.2 years.…”
-
5414
Image 4_Changes in symptom pattern in Meniere's disease by duration: the need for comprehensive management.tif
Published 2024“…The study population comprised 79.5% females and 20.5% males, with a mean age of 63 years and an average disease duration of 15.2 years.…”
-
5415
Image 5_Changes in symptom pattern in Meniere's disease by duration: the need for comprehensive management.tif
Published 2024“…The study population comprised 79.5% females and 20.5% males, with a mean age of 63 years and an average disease duration of 15.2 years.…”
-
5416
Table 1_Association between the composite dietary antioxidant index and cardiovascular-kidney-metabolic syndrome among U.S. adults: evidence from NHANES 2007–2018.docx
Published 2025“…</p>Results<p>This study included 11,073 adults aged 20 years and older, with a mean age of 48 years and a gender distribution of 52.75% female and 47.25% male. …”
-
5417
Image 1_Changes in symptom pattern in Meniere's disease by duration: the need for comprehensive management.tif
Published 2024“…The study population comprised 79.5% females and 20.5% males, with a mean age of 63 years and an average disease duration of 15.2 years.…”
-
5418
Image 2_Changes in symptom pattern in Meniere's disease by duration: the need for comprehensive management.tif
Published 2024“…The study population comprised 79.5% females and 20.5% males, with a mean age of 63 years and an average disease duration of 15.2 years.…”
-
5419
Data Sheet 1_Changes in symptom pattern in Meniere's disease by duration: the need for comprehensive management.pdf
Published 2024“…The study population comprised 79.5% females and 20.5% males, with a mean age of 63 years and an average disease duration of 15.2 years.…”
-
5420
Supplementary Material for: Efficacy and safety of transdermal medical cannabis (THC:CBD: CBN formula) to treat painful diabetic peripheral neuropathy of the lower extremities
Published 2024“…Results: The intervention group demonstrated statistically significant reductions in NPSI-T scores across all measured dimensions (p<0.001). Mean total NPSI-T scores decreased markedly from 25.60 to 5.57 in the treatment cohort, contrasting with minimal reduction from 25.24 to 22.85 in the placebo group. …”